Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy

181Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

Collapsing glomerulopathy is a devastating renal disease that primarily affects African Americans and associates with numerous etiologies, such as HIV and auto-immune disease. The presence of APOL1 risk alleles associates with HIV-associated collapsing glomerulopathy, but it is unknown whether these risk alleles also associate with systemic lupus erythematosus (SLE) -associated collapsing glomerulopathy. Here, re-examination of 546 renal biopsies from African-American patients with SLE identified 26 cases of collapsing glomerulopathy, which we genotyped for APOL1 risk alleles using DNA extracted from archived biopsy tissue. APOL1 strongly associated with SLE-associated collapsing glomerulopathy ( P<0.001). In a recessive model, two APOL1 risk alleles conferred 5.4-fold (95% CI=2.4 to 12.1) higher odds of developing SLE-associated collapsing glomerulopathy (P<0.001). In conclusion, APOL1 genotyping of African-American patients with SLE might help identify patients at risk for collapsing glomerulopathy, an entity with a poor prognosis that is often resistant to treatment. Copyright © 2013 by the American Society of Nephrology.

Cite

CITATION STYLE

APA

Larsen, C. P., Beggs, M. L., Saeed, M., & Walker, P. D. (2013). Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. Journal of the American Society of Nephrology, 24(5), 722–725. https://doi.org/10.1681/ASN.2012121180

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free